Carregant...
Making Potent CAR T Cells Using Genetic Engineering and Synergistic Agents
SIMPLE SUMMARY: Although CAR T cells are regarded as a revolutionary drug in cancer treatment, however, it still has many limitations. To overcome the disadvantages of CAR T cell, many researchers have tried to optimize the CAR gene. In this review, I summarized the current studies regarding genetic...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8269169/ https://ncbi.nlm.nih.gov/pubmed/34209505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133236 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|